Showing results (31-40 of 65) with videos related to
Sort By:
Pageof 7
Pharmacological Research|December 1, 2018
Small molecule inhibitors targeting the EGFR/ErbB family of protein-tyrosine kinases in human cancersRobert RoskoskiPharmacological Research|December 14, 2016
Allosteric MEK1/2 inhibitors including cobimetanib and trametinib in the treatment of cutaneous melanomasRobert RoskoskiBiochemical and Biophysical Research Communications|September 1, 2005
Signaling by Kit protein-tyrosine kinase--the stem cell factor receptorRobert RoskoskiPharmacological Research|May 4, 2017
ROS1 protein-tyrosine kinase inhibitors in the treatment of ROS1 fusion protein-driven non-small cell lung cancersRobert RoskoskiPharmacological Research|April 29, 2018
The role of small molecule Kit protein-tyrosine kinase inhibitors in the treatment of neoplastic disordersRobert RoskoskiBiochemical and Biophysical Research Communications|May 26, 2004
The ErbB/HER receptor protein-tyrosine kinases and cancerRobert RoskoskiBiochemical and Biophysical Research Communications|August 6, 2008
VEGF receptor protein-tyrosine kinases: structure and regulationRobert RoskoskiBiochemical and Biophysical Research Communications|April 23, 2005
Src kinase regulation by phosphorylation and dephosphorylationRobert RoskoskiPharmacological Research|May 10, 2026
FDA-approved RET protein-tyrosine kinase inhibitors in the management of RET-driven thyroid and lung cancerRobert RoskoskiPharmacological Research|March 24, 2017
Vascular endothelial growth factor (VEGF) and VEGF receptor inhibitors in the treatment of renal cell carcinomasRobert RoskoskiPageof 7